SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-22-000012
Filing Date
2022-05-12
Accepted
2022-05-12 16:07:45
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sls-20220331.htm   iXBRL 10-Q 870943
2 EX-10.1 sls-20220331ex101.htm EX-10.1 323937
3 EX-31.1 sls-20220331ex311.htm EX-31.1 8298
4 EX-31.2 sls-20220331ex312.htm EX-31.2 8302
5 EX-32.1 sls-20220331ex321.htm EX-32.1 6712
11 sls-20220331_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-22-000012.txt   5400192

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20220331.xsd EX-101.SCH 43437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20220331_cal.xml EX-101.CAL 51318
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20220331_def.xml EX-101.DEF 180389
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20220331_lab.xml EX-101.LAB 495599
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20220331_pre.xml EX-101.PRE 331432
62 EXTRACTED XBRL INSTANCE DOCUMENT sls-20220331_htm.xml XML 742378
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 22917821
SIC: 2834 Pharmaceutical Preparations